Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026)

Talphera's (TLPH) quarterly Other Non-Current Liabilities came in at $1.2 million in Q1 2026, up 31.02% year-on-year from $880000.0 in Q1 2025, and down 51.47% quarter-over-quarter from $2.4 million in Q4 2025.

Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Talphera's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 31.02% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 31.02% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 123.94% from the prior year.
  • Other Non-Current Liabilities slipped to $1.2 million in Q1 2026 per TLPH's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $84.6 million in Q1 2022 and bottomed at $759000.0 in Q2 2025.
  • The 5-year median for Other Non-Current Liabilities is $1.9 million (2025), against an average of $8.5 million.
  • Across the five-year window, Other Non-Current Liabilities jumped 46648.62% in 2022 and slumped 97.89% in 2023, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $7.1 million in 2022, then tumbled by 74.95% to $1.8 million in 2023, then sank by 40.33% to $1.1 million in 2024, then surged by 123.94% to $2.4 million in 2025, then plunged by 51.47% to $1.2 million in 2026.
  • Per Business Quant, the three latest TLPH Other Non-Current Liabilities figures stand at $1.2 million (Q1 2026), $2.4 million (Q4 2025), and $1.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Talphera 47.31 Mn 9.48 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.15 Mn
Dec 31, 2025 2.38 Mn
Sep 30, 2025 1.85 Mn
Jun 30, 2025 759,000.00
Mar 31, 2025 880,000.00
Dec 31, 2024 1.06 Mn
Sep 30, 2024 2.08 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 2.78 Mn
Dec 31, 2023 1.78 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 7.10 Mn
Mar 31, 2022 84.62 Mn
Dec 31, 2021 85.29 Mn
Sep 30, 2021 109,000.00
Jun 30, 2021 128,000.00
Mar 31, 2021 181,000.00
Dec 31, 2020 88.37 Mn
Sep 30, 2020 506,000.00
Jun 30, 2020 591,000.00